Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

Julie St-Pierre ¹, Stavit Drori , Marc Uldry

⁰Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

Cell +

|

October 24, 2006

View abstract on PubMed

Summary

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) regulates reactive oxygen species (ROS) metabolism. PGC-1alpha is essential for detoxifying ROS and protecting neural cells from oxidative stress.

Area Of Science

Cellular metabolism
Neurobiology
Oxidative stress

Background

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) stimulates mitochondrial biogenesis and respiration.
The mitochondrial electron transport chain is a primary source of reactive oxygen species (ROS).

Purpose Of The Study

To investigate the role of PGC-1alpha in regulating ROS metabolism.
To determine if PGC-1alpha influences the expression of ROS-detoxifying enzymes.
To assess the neuroprotective effects of PGC-1alpha against oxidative stressors.

Main Methods

Studied PGC-1alpha expression and its coinduction with ROS-detoxifying enzymes (GPx1, SOD2) under oxidative stress.
Utilized RNA interference (RNAi) and null cell models to assess PGC-1alpha's necessity for enzyme induction.
Examined the sensitivity of PGC-1alpha null mice to neurotoxic agents (MPTP, kainic acid).
Assessed the protective effects of PGC-1alpha in neural cells exposed to oxidative stressors.

Main Results

PGC-1alpha is coinduced with key ROS-detoxifying enzymes upon oxidative stress.
PGC-1alpha is required for the induction of enzymes like GPx1 and SOD2.
PGC-1alpha null mice exhibit increased sensitivity to neurodegeneration induced by MPTP and kainic acid.
Elevated PGC-1alpha levels protect cultured neural cells from oxidative stress-induced death.

Conclusions

PGC-1alpha is a significant regulator of cellular ROS metabolism.
PGC-1alpha plays a crucial role in the defense against oxidative stress and neurodegeneration.
Targeting PGC-1alpha may offer therapeutic strategies for conditions involving ROS-related damage.

Related Concept Videos